Endogenous Opioid Response to Injections

NCT06666621 · clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
33
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Middle Tennessee Research Institute

Collaborators